Your shopping cart is currently empty

MYBMIM is an inhibitor of the MYB:CBP/P300 assembly complex [MYB:CBP/P300]. It suppresses the growth of leukemia cells.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MYBMIM is an inhibitor of the MYB:CBP/P300 assembly complex [MYB:CBP/P300]. It suppresses the growth of leukemia cells. |
| In vitro | MYBMIM (10-20 μM) inhibits the proliferation of acute myeloid leukemia cells over 6 days and induces apoptosis within 48 hours by downregulating the expression of the anti-apoptotic Bcl2 gene. |
| In vivo | MYBMIM (25 mg/kg, administered intraperitoneally twice daily for 14 consecutive days) effectively inhibits the progression of human leukemia tumors in a mouse xenograft model. |
| Formula | C166H296N60O45S |
| Sequence | Ac-d-{Lys-Leu-Glu-Asn-Glu-Thr-Ser-Met-Leu-Leu-Leu-Glu-Leu-Glu-Lys-Ile-Arg-Lys-Gly-Gly-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly-Tyr}-NH2 |
| Sequence Short | d-{KLENETSMLLLELEKIRKGG-RRRQRRKKRGY} |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.